ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pruritus Type Skin Diseases Medicine Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-3G14699
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pruritus Type Skin Diseases Medicine Market Research Report 2023
BUY CHAPTERS

Global Pruritus Type Skin Diseases Medicine Market Research Report 2025

Code: QYRE-Auto-3G14699
Report
May 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbvie inc. (Allergan Plc)
Albireo Pharma Inc
GSK
Merck& Co. Inc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Viatris Inc. (Mylan N.V.)
Astellas Pharma Inc
Eli Lilly and Company
Cipla Ltd

Pruritus Type Skin Diseases Medicine Market Size

The global market for Pruritus Type Skin Diseases Medicine was valued at US$ 5411 million in the year 2024 and is projected to reach a revised size of US$ 7331 million by 2031, growing at a CAGR of 4.5% during the forecast period.

Pruritus Type Skin Diseases Medicine Market

Pruritus Type Skin Diseases Medicine Market

North American market for Pruritus Type Skin Diseases Medicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pruritus Type Skin Diseases Medicine is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Pruritus Type Skin Diseases Medicine include AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited, Eli Lilly and Company, GSK plc, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc. (Mylan N.V.), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pruritus Type Skin Diseases Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pruritus Type Skin Diseases Medicine.
The Pruritus Type Skin Diseases Medicine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pruritus Type Skin Diseases Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pruritus Type Skin Diseases Medicine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Pruritus Type Skin Diseases Medicine Market Report

Report Metric Details
Report Name Pruritus Type Skin Diseases Medicine Market
Accounted market size in year US$ 5411 million
Forecasted market size in 2031 US$ 7331 million
CAGR 4.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • External Medication
  • Oral Medication
Segment by Application
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited, Eli Lilly and Company, GSK plc, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc. (Mylan N.V.)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Pruritus Type Skin Diseases Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Pruritus Type Skin Diseases Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Pruritus Type Skin Diseases Medicine Market growing?

Ans: The Pruritus Type Skin Diseases Medicine Market witnessing a CAGR of 4.5% during the forecast period 2025-2031.

What is the Pruritus Type Skin Diseases Medicine Market size in 2031?

Ans: The Pruritus Type Skin Diseases Medicine Market size in 2031 will be US$ 7331 million.

Who are the main players in the Pruritus Type Skin Diseases Medicine Market report?

Ans: The main players in the Pruritus Type Skin Diseases Medicine Market are AbbVie, Inc. (Allergan plc), Albireo Pharma, Inc., Astellas Pharma Inc., Cipla Limited, Eli Lilly and Company, GSK plc, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Viatris Inc. (Mylan N.V.)

What are the Application segmentation covered in the Pruritus Type Skin Diseases Medicine Market report?

Ans: The Applications covered in the Pruritus Type Skin Diseases Medicine Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Pruritus Type Skin Diseases Medicine Market report?

Ans: The Types covered in the Pruritus Type Skin Diseases Medicine Market report are External Medication, Oral Medication

1 Pruritus Type Skin Diseases Medicine Market Overview
1.1 Product Definition
1.2 Pruritus Type Skin Diseases Medicine by Type
1.2.1 Global Pruritus Type Skin Diseases Medicine Market Value Comparison by Type (2024 VS 2031)
1.2.2 External Medication
1.2.3 Oral Medication
1.3 Pruritus Type Skin Diseases Medicine by Application
1.3.1 Global Pruritus Type Skin Diseases Medicine Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Pruritus Type Skin Diseases Medicine Market Size Estimates and Forecasts
1.4.1 Global Pruritus Type Skin Diseases Medicine Revenue 2020-2031
1.4.2 Global Pruritus Type Skin Diseases Medicine Sales 2020-2031
1.4.3 Global Pruritus Type Skin Diseases Medicine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pruritus Type Skin Diseases Medicine Market Competition by Manufacturers
2.1 Global Pruritus Type Skin Diseases Medicine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pruritus Type Skin Diseases Medicine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pruritus Type Skin Diseases Medicine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pruritus Type Skin Diseases Medicine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pruritus Type Skin Diseases Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pruritus Type Skin Diseases Medicine, Product Type & Application
2.7 Global Key Manufacturers of Pruritus Type Skin Diseases Medicine, Date of Enter into This Industry
2.8 Global Pruritus Type Skin Diseases Medicine Market Competitive Situation and Trends
2.8.1 Global Pruritus Type Skin Diseases Medicine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pruritus Type Skin Diseases Medicine Players Market Share by Revenue
2.8.3 Global Pruritus Type Skin Diseases Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pruritus Type Skin Diseases Medicine Market Scenario by Region
3.1 Global Pruritus Type Skin Diseases Medicine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pruritus Type Skin Diseases Medicine Sales by Region: 2020-2031
3.2.1 Global Pruritus Type Skin Diseases Medicine Sales by Region: 2020-2025
3.2.2 Global Pruritus Type Skin Diseases Medicine Sales by Region: 2026-2031
3.3 Global Pruritus Type Skin Diseases Medicine Revenue by Region: 2020-2031
3.3.1 Global Pruritus Type Skin Diseases Medicine Revenue by Region: 2020-2025
3.3.2 Global Pruritus Type Skin Diseases Medicine Revenue by Region: 2026-2031
3.4 North America Pruritus Type Skin Diseases Medicine Market Facts & Figures by Country
3.4.1 North America Pruritus Type Skin Diseases Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pruritus Type Skin Diseases Medicine Sales by Country (2020-2031)
3.4.3 North America Pruritus Type Skin Diseases Medicine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pruritus Type Skin Diseases Medicine Market Facts & Figures by Country
3.5.1 Europe Pruritus Type Skin Diseases Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pruritus Type Skin Diseases Medicine Sales by Country (2020-2031)
3.5.3 Europe Pruritus Type Skin Diseases Medicine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pruritus Type Skin Diseases Medicine Market Facts & Figures by Region
3.6.1 Asia Pacific Pruritus Type Skin Diseases Medicine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pruritus Type Skin Diseases Medicine Sales by Region (2020-2031)
3.6.3 Asia Pacific Pruritus Type Skin Diseases Medicine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pruritus Type Skin Diseases Medicine Market Facts & Figures by Country
3.7.1 Latin America Pruritus Type Skin Diseases Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pruritus Type Skin Diseases Medicine Sales by Country (2020-2031)
3.7.3 Latin America Pruritus Type Skin Diseases Medicine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pruritus Type Skin Diseases Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pruritus Type Skin Diseases Medicine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pruritus Type Skin Diseases Medicine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pruritus Type Skin Diseases Medicine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pruritus Type Skin Diseases Medicine Sales by Type (2020-2031)
4.1.1 Global Pruritus Type Skin Diseases Medicine Sales by Type (2020-2025)
4.1.2 Global Pruritus Type Skin Diseases Medicine Sales by Type (2026-2031)
4.1.3 Global Pruritus Type Skin Diseases Medicine Sales Market Share by Type (2020-2031)
4.2 Global Pruritus Type Skin Diseases Medicine Revenue by Type (2020-2031)
4.2.1 Global Pruritus Type Skin Diseases Medicine Revenue by Type (2020-2025)
4.2.2 Global Pruritus Type Skin Diseases Medicine Revenue by Type (2026-2031)
4.2.3 Global Pruritus Type Skin Diseases Medicine Revenue Market Share by Type (2020-2031)
4.3 Global Pruritus Type Skin Diseases Medicine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pruritus Type Skin Diseases Medicine Sales by Application (2020-2031)
5.1.1 Global Pruritus Type Skin Diseases Medicine Sales by Application (2020-2025)
5.1.2 Global Pruritus Type Skin Diseases Medicine Sales by Application (2026-2031)
5.1.3 Global Pruritus Type Skin Diseases Medicine Sales Market Share by Application (2020-2031)
5.2 Global Pruritus Type Skin Diseases Medicine Revenue by Application (2020-2031)
5.2.1 Global Pruritus Type Skin Diseases Medicine Revenue by Application (2020-2025)
5.2.2 Global Pruritus Type Skin Diseases Medicine Revenue by Application (2026-2031)
5.2.3 Global Pruritus Type Skin Diseases Medicine Revenue Market Share by Application (2020-2031)
5.3 Global Pruritus Type Skin Diseases Medicine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 AbbVie, Inc. (Allergan plc)
6.1.1 AbbVie, Inc. (Allergan plc) Company Information
6.1.2 AbbVie, Inc. (Allergan plc) Description and Business Overview
6.1.3 AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Product Portfolio
6.1.5 AbbVie, Inc. (Allergan plc) Recent Developments/Updates
6.2 Albireo Pharma, Inc.
6.2.1 Albireo Pharma, Inc. Company Information
6.2.2 Albireo Pharma, Inc. Description and Business Overview
6.2.3 Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Product Portfolio
6.2.5 Albireo Pharma, Inc. Recent Developments/Updates
6.3 Astellas Pharma Inc.
6.3.1 Astellas Pharma Inc. Company Information
6.3.2 Astellas Pharma Inc. Description and Business Overview
6.3.3 Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Product Portfolio
6.3.5 Astellas Pharma Inc. Recent Developments/Updates
6.4 Cipla Limited
6.4.1 Cipla Limited Company Information
6.4.2 Cipla Limited Description and Business Overview
6.4.3 Cipla Limited Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Cipla Limited Pruritus Type Skin Diseases Medicine Product Portfolio
6.4.5 Cipla Limited Recent Developments/Updates
6.5 Eli Lilly and Company
6.5.1 Eli Lilly and Company Company Information
6.5.2 Eli Lilly and Company Description and Business Overview
6.5.3 Eli Lilly and Company Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Eli Lilly and Company Pruritus Type Skin Diseases Medicine Product Portfolio
6.5.5 Eli Lilly and Company Recent Developments/Updates
6.6 GSK plc
6.6.1 GSK plc Company Information
6.6.2 GSK plc Description and Business Overview
6.6.3 GSK plc Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 GSK plc Pruritus Type Skin Diseases Medicine Product Portfolio
6.6.5 GSK plc Recent Developments/Updates
6.7 Merck & Co., Inc.
6.7.1 Merck & Co., Inc. Company Information
6.7.2 Merck & Co., Inc. Description and Business Overview
6.7.3 Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Product Portfolio
6.7.5 Merck & Co., Inc. Recent Developments/Updates
6.8 Pfizer, Inc.
6.8.1 Pfizer, Inc. Company Information
6.8.2 Pfizer, Inc. Description and Business Overview
6.8.3 Pfizer, Inc. Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer, Inc. Pruritus Type Skin Diseases Medicine Product Portfolio
6.8.5 Pfizer, Inc. Recent Developments/Updates
6.9 Teva Pharmaceutical Industries Ltd.
6.9.1 Teva Pharmaceutical Industries Ltd. Company Information
6.9.2 Teva Pharmaceutical Industries Ltd. Description and Business Overview
6.9.3 Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Product Portfolio
6.9.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
6.10 Viatris Inc. (Mylan N.V.)
6.10.1 Viatris Inc. (Mylan N.V.) Company Information
6.10.2 Viatris Inc. (Mylan N.V.) Description and Business Overview
6.10.3 Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Product Portfolio
6.10.5 Viatris Inc. (Mylan N.V.) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pruritus Type Skin Diseases Medicine Industry Chain Analysis
7.2 Pruritus Type Skin Diseases Medicine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pruritus Type Skin Diseases Medicine Production Mode & Process Analysis
7.4 Pruritus Type Skin Diseases Medicine Sales and Marketing
7.4.1 Pruritus Type Skin Diseases Medicine Sales Channels
7.4.2 Pruritus Type Skin Diseases Medicine Distributors
7.5 Pruritus Type Skin Diseases Medicine Customer Analysis
8 Pruritus Type Skin Diseases Medicine Market Dynamics
8.1 Pruritus Type Skin Diseases Medicine Industry Trends
8.2 Pruritus Type Skin Diseases Medicine Market Drivers
8.3 Pruritus Type Skin Diseases Medicine Market Challenges
8.4 Pruritus Type Skin Diseases Medicine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbvie inc. (Allergan Plc)
Albireo Pharma Inc
GSK
Merck& Co. Inc
Pfizer Inc
Teva Pharmaceutical Industries Ltd
Viatris Inc. (Mylan N.V.)
Astellas Pharma Inc
Eli Lilly and Company
Cipla Ltd
List of Tables
 Table 1. Global Pruritus Type Skin Diseases Medicine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Pruritus Type Skin Diseases Medicine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Pruritus Type Skin Diseases Medicine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Pruritus Type Skin Diseases Medicine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Pruritus Type Skin Diseases Medicine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Pruritus Type Skin Diseases Medicine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Pruritus Type Skin Diseases Medicine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Pruritus Type Skin Diseases Medicine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Pruritus Type Skin Diseases Medicine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Pruritus Type Skin Diseases Medicine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Pruritus Type Skin Diseases Medicine, Product Type & Application
 Table 12. Global Key Manufacturers of Pruritus Type Skin Diseases Medicine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Pruritus Type Skin Diseases Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Type Skin Diseases Medicine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Pruritus Type Skin Diseases Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Pruritus Type Skin Diseases Medicine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Pruritus Type Skin Diseases Medicine Sales Market Share by Region (2020-2025)
 Table 19. Global Pruritus Type Skin Diseases Medicine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Pruritus Type Skin Diseases Medicine Sales Market Share by Region (2026-2031)
 Table 21. Global Pruritus Type Skin Diseases Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Pruritus Type Skin Diseases Medicine Revenue Market Share by Region (2020-2025)
 Table 23. Global Pruritus Type Skin Diseases Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Pruritus Type Skin Diseases Medicine Revenue Market Share by Region (2026-2031)
 Table 25. North America Pruritus Type Skin Diseases Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Pruritus Type Skin Diseases Medicine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Pruritus Type Skin Diseases Medicine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Pruritus Type Skin Diseases Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Pruritus Type Skin Diseases Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Pruritus Type Skin Diseases Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Pruritus Type Skin Diseases Medicine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Pruritus Type Skin Diseases Medicine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Pruritus Type Skin Diseases Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Pruritus Type Skin Diseases Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Pruritus Type Skin Diseases Medicine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Pruritus Type Skin Diseases Medicine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Pruritus Type Skin Diseases Medicine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Pruritus Type Skin Diseases Medicine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Pruritus Type Skin Diseases Medicine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pruritus Type Skin Diseases Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Pruritus Type Skin Diseases Medicine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Pruritus Type Skin Diseases Medicine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Pruritus Type Skin Diseases Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Pruritus Type Skin Diseases Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Pruritus Type Skin Diseases Medicine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Pruritus Type Skin Diseases Medicine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Pruritus Type Skin Diseases Medicine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Pruritus Type Skin Diseases Medicine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Pruritus Type Skin Diseases Medicine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Pruritus Type Skin Diseases Medicine Sales (K Units) by Type (2020-2025)
 Table 51. Global Pruritus Type Skin Diseases Medicine Sales (K Units) by Type (2026-2031)
 Table 52. Global Pruritus Type Skin Diseases Medicine Sales Market Share by Type (2020-2025)
 Table 53. Global Pruritus Type Skin Diseases Medicine Sales Market Share by Type (2026-2031)
 Table 54. Global Pruritus Type Skin Diseases Medicine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Pruritus Type Skin Diseases Medicine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Pruritus Type Skin Diseases Medicine Revenue Market Share by Type (2020-2025)
 Table 57. Global Pruritus Type Skin Diseases Medicine Revenue Market Share by Type (2026-2031)
 Table 58. Global Pruritus Type Skin Diseases Medicine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Pruritus Type Skin Diseases Medicine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Pruritus Type Skin Diseases Medicine Sales (K Units) by Application (2020-2025)
 Table 61. Global Pruritus Type Skin Diseases Medicine Sales (K Units) by Application (2026-2031)
 Table 62. Global Pruritus Type Skin Diseases Medicine Sales Market Share by Application (2020-2025)
 Table 63. Global Pruritus Type Skin Diseases Medicine Sales Market Share by Application (2026-2031)
 Table 64. Global Pruritus Type Skin Diseases Medicine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Pruritus Type Skin Diseases Medicine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Pruritus Type Skin Diseases Medicine Revenue Market Share by Application (2020-2025)
 Table 67. Global Pruritus Type Skin Diseases Medicine Revenue Market Share by Application (2026-2031)
 Table 68. Global Pruritus Type Skin Diseases Medicine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Pruritus Type Skin Diseases Medicine Price (US$/Unit) by Application (2026-2031)
 Table 70. AbbVie, Inc. (Allergan plc) Company Information
 Table 71. AbbVie, Inc. (Allergan plc) Description and Business Overview
 Table 72. AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. AbbVie, Inc. (Allergan plc) Pruritus Type Skin Diseases Medicine Product
 Table 74. AbbVie, Inc. (Allergan plc) Recent Developments/Updates
 Table 75. Albireo Pharma, Inc. Company Information
 Table 76. Albireo Pharma, Inc. Description and Business Overview
 Table 77. Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Albireo Pharma, Inc. Pruritus Type Skin Diseases Medicine Product
 Table 79. Albireo Pharma, Inc. Recent Developments/Updates
 Table 80. Astellas Pharma Inc. Company Information
 Table 81. Astellas Pharma Inc. Description and Business Overview
 Table 82. Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Astellas Pharma Inc. Pruritus Type Skin Diseases Medicine Product
 Table 84. Astellas Pharma Inc. Recent Developments/Updates
 Table 85. Cipla Limited Company Information
 Table 86. Cipla Limited Description and Business Overview
 Table 87. Cipla Limited Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Cipla Limited Pruritus Type Skin Diseases Medicine Product
 Table 89. Cipla Limited Recent Developments/Updates
 Table 90. Eli Lilly and Company Company Information
 Table 91. Eli Lilly and Company Description and Business Overview
 Table 92. Eli Lilly and Company Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Eli Lilly and Company Pruritus Type Skin Diseases Medicine Product
 Table 94. Eli Lilly and Company Recent Developments/Updates
 Table 95. GSK plc Company Information
 Table 96. GSK plc Description and Business Overview
 Table 97. GSK plc Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. GSK plc Pruritus Type Skin Diseases Medicine Product
 Table 99. GSK plc Recent Developments/Updates
 Table 100. Merck & Co., Inc. Company Information
 Table 101. Merck & Co., Inc. Description and Business Overview
 Table 102. Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Merck & Co., Inc. Pruritus Type Skin Diseases Medicine Product
 Table 104. Merck & Co., Inc. Recent Developments/Updates
 Table 105. Pfizer, Inc. Company Information
 Table 106. Pfizer, Inc. Description and Business Overview
 Table 107. Pfizer, Inc. Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Pfizer, Inc. Pruritus Type Skin Diseases Medicine Product
 Table 109. Pfizer, Inc. Recent Developments/Updates
 Table 110. Teva Pharmaceutical Industries Ltd. Company Information
 Table 111. Teva Pharmaceutical Industries Ltd. Description and Business Overview
 Table 112. Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Teva Pharmaceutical Industries Ltd. Pruritus Type Skin Diseases Medicine Product
 Table 114. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 115. Viatris Inc. (Mylan N.V.) Company Information
 Table 116. Viatris Inc. (Mylan N.V.) Description and Business Overview
 Table 117. Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Viatris Inc. (Mylan N.V.) Pruritus Type Skin Diseases Medicine Product
 Table 119. Viatris Inc. (Mylan N.V.) Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Pruritus Type Skin Diseases Medicine Distributors List
 Table 123. Pruritus Type Skin Diseases Medicine Customers List
 Table 124. Pruritus Type Skin Diseases Medicine Market Trends
 Table 125. Pruritus Type Skin Diseases Medicine Market Drivers
 Table 126. Pruritus Type Skin Diseases Medicine Market Challenges
 Table 127. Pruritus Type Skin Diseases Medicine Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Pruritus Type Skin Diseases Medicine
 Figure 2. Global Pruritus Type Skin Diseases Medicine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pruritus Type Skin Diseases Medicine Market Share by Type: 2024 & 2031
 Figure 4. External Medication Product Picture
 Figure 5. Oral Medication Product Picture
 Figure 6. Global Pruritus Type Skin Diseases Medicine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pruritus Type Skin Diseases Medicine Market Share by Application: 2024 & 2031
 Figure 8. Hospital Pharmacies
 Figure 9. Retail Pharmacies
 Figure 10. Online Pharmacies
 Figure 11. Global Pruritus Type Skin Diseases Medicine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Pruritus Type Skin Diseases Medicine Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Pruritus Type Skin Diseases Medicine Sales (2020-2031) & (K Units)
 Figure 14. Global Pruritus Type Skin Diseases Medicine Average Price (US$/Unit) & (2020-2031)
 Figure 15. Pruritus Type Skin Diseases Medicine Report Years Considered
 Figure 16. Pruritus Type Skin Diseases Medicine Sales Share by Manufacturers in 2024
 Figure 17. Global Pruritus Type Skin Diseases Medicine Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Pruritus Type Skin Diseases Medicine Players: Market Share by Revenue in Pruritus Type Skin Diseases Medicine in 2024
 Figure 19. Pruritus Type Skin Diseases Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Pruritus Type Skin Diseases Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Pruritus Type Skin Diseases Medicine Sales Market Share by Country (2020-2031)
 Figure 22. North America Pruritus Type Skin Diseases Medicine Revenue Market Share by Country (2020-2031)
 Figure 23. United States Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Pruritus Type Skin Diseases Medicine Sales Market Share by Country (2020-2031)
 Figure 26. Europe Pruritus Type Skin Diseases Medicine Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Pruritus Type Skin Diseases Medicine Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Pruritus Type Skin Diseases Medicine Revenue Market Share by Region (2020-2031)
 Figure 34. China Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Pruritus Type Skin Diseases Medicine Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Pruritus Type Skin Diseases Medicine Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Pruritus Type Skin Diseases Medicine Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Pruritus Type Skin Diseases Medicine Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Pruritus Type Skin Diseases Medicine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Pruritus Type Skin Diseases Medicine by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Pruritus Type Skin Diseases Medicine by Type (2020-2031)
 Figure 53. Global Pruritus Type Skin Diseases Medicine Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Pruritus Type Skin Diseases Medicine by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Pruritus Type Skin Diseases Medicine by Application (2020-2031)
 Figure 56. Global Pruritus Type Skin Diseases Medicine Price (US$/Unit) by Application (2020-2031)
 Figure 57. Pruritus Type Skin Diseases Medicine Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Pruritus Ani Medicine Market Research Report 2024
Global Pruritus Drugs Market Insights Forecast to 2030
Global Dermatological Medicine Market Research Report 2024
Medications for Actinic Prurigo Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Actinic Prurigo Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dermatological Disorders Medications Market Research Report 2024
Global Cholestasis Pruritus Treatment Market Research Report 2024
Medications for Prurigo Nodularis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global OTC Skin Medicine Market Research Report 2024
Global Pet Skin Disease Drugs Market Research Report 2025
Global Inflammatory Skin Diseases Treatment Market Research Report 2024
Nodular Prurigo Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Inflammatory Skin Diseases Drugs Market Research Report 2024
Global Seborrheic Dermatitis Medicine Market Research Report 2024
Global Atopic Dermatitis Medication Market Research Report 2025
Global OTC Topical Skin Medicine Market Research Report 2024
Global Dermatitis Drugs Market Research Report 2024
Global Prescription Dermatological Medications Market Research Report 2024
Global Dermatological Non Steroidal Anti Inflammatory Drugs Market Research Report 2024
Global Topical Medication for Vaginitis Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions